About Proto Labs (NYSE:PRLB)
Proto Labs, Inc., together with its subsidiaries, operates as an e-commerce enabled digital manufacturer of custom parts for prototyping and short-run production worldwide. It utilizes injection molding, computer numerical control machining, three-dimensional (3D) printing, and sheet metal fabrication to manufacture custom parts for developers and engineers who use 3D computer-aided design software to design products across a range of end markets. The company was founded in 1999 and is headquartered in Maple Plain, Minnesota.
Industry, Sector and Symbol
Industry Fabricated structural metal products
Sub-IndustryIndustrial Machinery
SectorIndustrial Products
SymbolNYSE:PRLB
CUSIP74371310
Phone763-479-3680
Debt
Debt-to-Equity RatioN/A
Current Ratio3.77%
Quick Ratio3.51%
Price-To-Earnings
Trailing P/E Ratio65.16
Forward P/E Ratio49.09
P/E Growth2.57
Sales & Book Value
Annual Sales$344.49 million
Price / Sales9.70
Cash Flow$2.6429 per share
Price / Cash46.99
Book Value$17.31 per share
Price / Book7.17
Profitability
EPS (Most Recent Fiscal Year)$1.93
Net Income$51.77 million
Net Margins15.03%
Return on Equity12.22%
Return on Assets11.00%
Miscellaneous
Employees2,266
Outstanding Shares26,900,000
Proto Labs (NYSE:PRLB) Frequently Asked Questions
What is Proto Labs' stock symbol?
Proto Labs trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRLB."
How will Proto Labs' stock buyback program work?
Proto Labs declared that its board has approved a stock buyback plan on Monday, April 10th 2017, which allows the company to buyback $50,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to reacquire up to 3.3% of its stock through open market purchases. Stock buyback plans are usually a sign that the company's leadership believes its shares are undervalued.
How were Proto Labs' earnings last quarter?
Proto Labs (NYSE:PRLB) released its quarterly earnings data on Thursday, February, 8th. The industrial products company reported $0.53 EPS for the quarter, topping the consensus estimate of $0.48 by $0.05. The industrial products company had revenue of $94.18 million for the quarter, compared to the consensus estimate of $92.20 million. Proto Labs had a net margin of 15.03% and a return on equity of 12.22%. Proto Labs's revenue was up 30.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.41 EPS. View Proto Labs' Earnings History.
When is Proto Labs' next earnings date?
What price target have analysts set for PRLB?
3 brokerages have issued 1-year price objectives for Proto Labs' stock. Their forecasts range from $45.00 to $92.00. On average, they anticipate Proto Labs' stock price to reach $73.6667 in the next twelve months. View Analyst Ratings for Proto Labs.
Who are some of Proto Labs' key competitors?
Some companies that are related to Proto Labs include Halma (HLMAF), Hubbell (HUBB), Reliance Steel & Aluminum (RS), CAE (CAE), PrairieSky Royalty (PSK), Smiths Group (SMIN), Flowserve (FLS), Lincoln Electric (LECO), Taylor Wimpey (TW), Donaldson (DCI), AptarGroup (ATR), G4S (GFSZY), Kawasaki Heavy Industries (KWHIY), Leonardo (LDO), IHI (IHICY), AGCO (AGCO), Sonoco (SON) and The Berkeley Group (BKG).
Who are Proto Labs' key executives?
Proto Labs' management team includes the folowing people:
- Ms. Victoria M. Holt, CEO, Pres & Director (Age 60)
- Mr. John A. Way, CFO & Exec. VP of Devel. (Age 45)
- Dr. Arthur Richard Baker III, Chief Technology Officer (Age 50)
- Dr. Robert Bodor, VP & GM of Americas (Age 45)
- Dan Schumacher, Director of Investor Relations and FP&A
Has Proto Labs been receiving favorable news coverage?
News stories about PRLB stock have been trending somewhat positive this week, Accern Sentiment reports. The research firm ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Proto Labs earned a news sentiment score of 0.07 on Accern's scale. They also assigned news stories about the industrial products company an impact score of 46.60 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.
How do I buy shares of Proto Labs?
Shares of PRLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Proto Labs' stock price today?
One share of PRLB stock can currently be purchased for approximately $124.45.
How big of a company is Proto Labs?
Proto Labs has a market capitalization of $3.38 billion and generates $344.49 million in revenue each year. The industrial products company earns $51.77 million in net income (profit) each year or $1.93 on an earnings per share basis. Proto Labs employs 2,266 workers across the globe.
How can I contact Proto Labs?
Proto Labs' mailing address is 5540 Pioneer Creek Drive, Maple Plain MN, 55359. The industrial products company can be reached via phone at 763-479-3680 or via email at [email protected]
MarketBeat Community Rating for Proto Labs (PRLB)
MarketBeat's community ratings are surveys of what our community members think about Proto Labs and other stocks. Vote "Outperform" if you believe PRLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
Proto Labs (NYSE:PRLB) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
3 Wall Street analysts have issued ratings and price targets for Proto Labs in the last 12 months. Their average twelve-month price target is $73.6667, suggesting that the stock has a possible downside of 40.68%. The high price target for PRLB is $92.00 and the low price target for PRLB is $45.00. There are currently 3 hold ratings for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 2.00 | 2.00 | 2.00 | 2.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $73.6667 | $73.6667 | $73.6667 | $56.00 |
| Price Target Upside: | 40.68% downside | 25.55% downside | 25.55% downside | 24.32% downside |
Proto Labs (NYSE:PRLB) Consensus Price Target History
Proto Labs (NYSE:PRLB) Analyst Ratings History
Show:
(Data available from 4/23/2016 forward)
Proto Labs (NYSE:PRLB) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Proto Labs (NYSE PRLB) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 0.64%
Institutional Ownership Percentage: 98.12%
Proto Labs (NYSE PRLB) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/14/2018 | John B Goodman | Director | Sell | 1,114 | $122.71 | $136,698.94 | 11,091 |  |
| 2/13/2018 | Robert Bodor | VP | Sell | 1,891 | $106.00 | $200,446.00 | | |
| 2/12/2018 | John B Goodman | Director | Sell | 2,715 | $106.79 | $289,934.85 | | |
| 1/2/2018 | Rainer Gawlick | Director | Sell | 500 | $102.75 | $51,375.00 | 10,925 | |
| 12/11/2017 | Robert Bodor | VP | Sell | 4,000 | $94.79 | $379,160.00 | 20,578 | |
| 11/22/2017 | John B Tumelty | VP | Sell | 13,556 | $92.07 | $1,248,100.92 | | |
| 11/21/2017 | Rainer Gawlick | Director | Sell | 1,500 | $90.31 | $135,465.00 | 6,925 | |
| 7/27/2017 | Robert Bodor | VP | Sell | 741 | $73.84 | $54,715.44 | 17,319 | |
| 7/19/2017 | Robert Bodor | VP | Sell | 3,259 | $72.02 | $234,713.18 | 19,837 | |
| 5/22/2017 | Rainer Gawlick | Director | Sell | 833 | $64.05 | $53,353.65 | 6,258 | |
| 5/8/2017 | John B Tumelty | Director | Sell | 11,896 | $61.72 | $734,221.12 | 4,299 | |
| 2/15/2017 | John B Tumelty | VP | Sell | 862 | $56.78 | $48,944.36 | 17,057 | |
| 2/15/2017 | Victoria M Holt | Insider | Sell | 2,025 | $56.80 | $115,020.00 | 44,018 | |
| 9/1/2016 | Arthur R Baker III | Insider | Buy | 3,000 | $55.00 | $165,000.00 | 7,105 | |
| 5/19/2016 | Rainer Gawlick | Director | Sell | 357 | $61.20 | $21,848.40 | 3,007 | |
| 4/14/2016 | Rainer Gawlick | Director | Sell | 4,000 | $80.00 | $320,000.00 | 7,364 | |
| 4/4/2016 | Jacqueline D Schneider | VP | Sell | 19,844 | $77.66 | $1,541,085.04 | 24,827 | |
| 3/31/2016 | John B Tumelty | Director | Sell | 21,000 | $77.51 | $1,627,710.00 | 31,627 | |
| 3/7/2016 | John B Goodman | Director | Sell | 1,000 | $73.56 | $73,560.00 | 8,263 | |
| 2/17/2016 | Jacqueline D Schneider | VP | Sell | 313 | $63.52 | $19,881.76 | 10,827 | |
| 2/17/2016 | John B Tumelty | Director | Sell | 410 | $63.94 | $26,215.40 | 10,627 | |
| 8/17/2015 | John B Tumelty | Director | Sell | 9,400 | $73.83 | $694,002.00 | | |
| 7/23/2015 | Jacqueline D Schneider | VP | Sell | 30,000 | $74.75 | $2,242,500.00 | | |
| 7/1/2015 | John B Goodman | Director | Sell | 500 | $67.50 | $33,750.00 | | |
| 4/16/2015 | Donald G Krantz | VP | Sell | 1,195 | $79.00 | $94,405.00 | | |
| 4/15/2015 | Jacqueline D Schneider | VP | Sell | 2,000 | $77.80 | $155,600.00 | | |
| 4/13/2015 | John B Tumelty | Director | Sell | 21,000 | $75.07 | $1,576,470.00 | | |
| 10/3/2014 | John B Goodman | Director | Sell | 1,000 | $70.20 | $70,200.00 | | |
| 10/1/2014 | John B Goodman | Director | Sell | 2,000 | $68.35 | $136,700.00 | | |
| 7/31/2014 | John R Judd | CFO | Sell | 75,000 | $80.84 | $6,063,000.00 | | |
| 7/1/2014 | Jacqueline D Schneider | VP | Sell | 14,000 | $88.98 | $1,245,720.00 | | |
| 7/1/2014 | John B Goodman | Director | Sell | 3,000 | $82.91 | $248,730.00 | | |
| 6/26/2014 | Rainer Gawlick | Director | Sell | 1,000 | $80.42 | $80,420.00 | | |
| 4/2/2014 | John Goodman | Director | Sell | 6,762 | $71.16 | $481,183.92 | 6,250 | |
| 2/19/2014 | Lawrence Lukis | Chairman | Sell | 1,000,000 | $76.00 | $76,000,000.00 | 2,806,840 | |
| 2/13/2014 | Victoria Holt | CEO | Buy | 3,200 | $78.64 | $251,648.00 | 15,928 | |
| 2/7/2014 | Robert Bodor | CTO | Sell | 4,000 | $80.37 | $321,480.00 | | |
| 1/6/2014 | John Tumelty | Insider | Sell | 4,464 | $73.02 | $325,961.28 | | |
| 11/21/2013 | John Tumelty | Insider | Sell | 1,750 | $77.00 | $134,750.00 | | |
| 11/12/2013 | Jacqueline Schneider | VP | Sell | 2,000 | $88.90 | $177,800.00 | 1,250 | |
| 11/7/2013 | Bradley Cleveland | CEO | Sell | 134,564 | $81.97 | $11,030,211.08 | | |
| 11/5/2013 | Bradley Cleveland | CEO | Sell | 93,250 | $86.20 | $8,038,150.00 | | |
| 11/1/2013 | John B Goodman | Director | Sell | 2,000 | $83.88 | $167,760.00 | | |
| 10/31/2013 | John R Judd | CFO | Sell | 50,000 | $76.96 | $3,848,000.00 | | |
| 10/21/2013 | Jacqueline D Schneider | VP | Sell | 2,000 | $83.90 | $167,800.00 | | |
| 10/21/2013 | John B Tumelty | Insider | Sell | 1,750 | $83.09 | $145,407.50 | | |
| 9/23/2013 | Jacqueline Schneider | VP | Sell | 2,000 | $78.92 | $157,840.00 | 1,250 | |
| 9/23/2013 | John Tumelty | Insider | Sell | 1,750 | $78.00 | $136,500.00 | | |
| 9/23/2013 | Rainer Gawlick | Director | Sell | 17,500 | $77.71 | $1,359,925.00 | 2,250 | |
| 9/10/2013 | Bradley A Cleveland | CEO | Sell | 95,000 | $74.30 | $7,058,500.00 | | |
| 9/9/2013 | Jacqueline D Schneider | VP | Sell | 2,000 | $73.90 | $147,800.00 | | |
| 9/4/2013 | Brian K Smith | Director | Sell | 10,177 | $74.85 | $761,748.45 | | |
| 9/3/2013 | Margaret Loftus | Director | Sell | 10,000 | $71.97 | $719,700.00 | 61,250 | |
| 8/21/2013 | John Tumelty | Insider | Sell | 1,750 | $68.43 | $119,752.50 | | |
| 8/5/2013 | Brian Smith | Director | Sell | 40,000 | $68.48 | $2,739,200.00 | 10,177 | |
| 8/5/2013 | Lawrence Lukis | Chairman | Sell | 1,000,000 | $65.57 | $65,570,000.00 | 4,106,840 | |
| 8/1/2013 | John B Goodman | Director | Sell | 2,000 | $63.79 | $127,580.00 | | |
| 8/1/2013 | John Judd | CFO | Sell | 50,000 | $63.77 | $3,188,500.00 | | |
| 7/22/2013 | John B Tumelty | Insider | Sell | 1,750 | $64.00 | $112,000.00 | | |
| 7/8/2013 | John B Tumelty | Insider | Sell | 10,500 | $64.69 | $679,245.00 | | |
| 7/1/2013 | Rainer Gawlick | Director | Sell | 2,000 | $65.80 | $131,600.00 | | |
| 5/30/2013 | Margaret A Loftus | Director | Sell | 10,000 | $53.83 | $538,300.00 | | |
| 5/29/2013 | Rainer Gawlick | Director | Sell | 2,000 | $53.40 | $106,800.00 | | |
| 5/10/2013 | Jacqueline D Schneider | VP | Sell | 7,000 | $57.80 | $404,600.00 | | |
| 5/2/2013 | Brian K Smith | Director | Sell | 64,000 | $50.50 | $3,232,000.00 | | |
| 5/1/2013 | John B Goodman | Director | Sell | 2,000 | $50.60 | $101,200.00 | | |
| 4/30/2013 | Bradley A Cleveland | CEO | Sell | 5,000 | $50.52 | $252,600.00 | | |
| 4/10/2013 | Donald G Krantz | COO | Sell | 42,000 | $50.56 | $2,123,520.00 | | |
| 1/16/2013 | William M Dietrick | VP | Sell | 32,000 | $42.30 | $1,353,600.00 | | |
| 12/3/2012 | Donald G Krantz | COO | Sell | 5,000 | $36.45 | $182,250.00 | | |
| 11/26/2012 | Donald G Krantz | COO | Sell | 2,490 | $35.06 | $87,299.40 | | |
| 10/31/2012 | Bradley A Cleveland | CEO | Sell | 29,000 | $34.22 | $992,380.00 | | |
| 10/3/2012 | Bradley A Cleveland | CEO | Sell | 9,000 | $33.56 | $302,040.00 | | |
| 10/2/2012 | Jacqueline D Schneider | VP | Sell | 8,250 | $34.00 | $280,500.00 | | |
| 10/2/2012 | Mark R Kubicek | EVP | Sell | 5,000 | $34.00 | $170,000.00 | | |
| 9/6/2012 | Mark R Kubicek | EVP | Sell | 50,000 | $30.78 | $1,539,000.00 | | |
| 9/5/2012 | Margaret A Loftus | Director | Sell | 45,000 | $30.71 | $1,381,950.00 | | |
| 9/4/2012 | Bradley A Cleveland | CEO | Sell | 4,500 | $31.01 | $139,545.00 | | |
| 8/23/2012 | Brian K Smith | Director | Sell | 20,000 | $32.25 | $645,000.00 | | |
(Data available from 1/1/2013 forward)
Proto Labs (NYSE PRLB) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Proto Labs (PRLB) and Valmont Industries (VMI) Head to Head Review
www.americanbankingnews.com - April 20 at 1:26 AM |
 | Notable Thursday Option Activity: PRLB, IDTI, SWK
www.nasdaq.com - April 19 at 5:22 PM |
| Proto Labs (PRLB) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 18 at 3:28 AM |
| Proto Labs Inc (PRLB) Expected to Post Quarterly Sales of $98.81 Million
www.americanbankingnews.com - April 15 at 2:30 AM |
| Proto Labs Inc (PRLB) Expected to Announce Earnings of $0.69 Per Share
www.americanbankingnews.com - April 13 at 7:13 PM |
| Proto Labs (PRLB) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 11 at 11:00 AM |
 | 3 Top Growth Stocks to Buy in April
finance.yahoo.com - April 11 at 9:26 AM |
| Protolabs Sets Conference Call to Discuss First Quarter 2018 Financial Results
finance.yahoo.com - April 10 at 4:58 PM |
| Proto Labs (PRLB) & Harsco (HSC) Head-To-Head Comparison
www.americanbankingnews.com - April 9 at 9:34 AM |
| Contrasting Proto Labs (PRLB) & HC2 (HCHC)
www.americanbankingnews.com - April 4 at 11:47 AM |
| Proto Labs (PRLB) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - April 1 at 9:48 PM |
| Proto Labs Inc (PRLB) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - April 1 at 11:22 AM |
| Zacks: Analysts Anticipate Proto Labs Inc (PRLB) Will Announce Quarterly Sales of $98.81 Million
www.americanbankingnews.com - March 29 at 4:00 AM |
| Proto Labs (PRLB) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - March 26 at 7:08 PM |
| 5 Growth Investing Options in Industrial Products Sector
finance.yahoo.com - March 21 at 5:19 PM |
| Is It Too Late To Buy Proto Labs Inc (NYSE:PRLB)?
finance.yahoo.com - March 21 at 8:56 AM |
| Market Trends Toward New Normal in First Midwest, Virtus Investment Partners, Blue Bird, Ares Management, Proto Labs, and Lancaster Colony — Emerging Consolidated Expectations, Analyst Ratings
finance.yahoo.com - March 20 at 8:41 AM |
| Proto Labs Works for Capacity Expansion, Adds New Facility
finance.yahoo.com - March 19 at 5:10 PM |
| Proto Labs Inc (PRLB) Director Sells $136,698.94 in Stock
www.americanbankingnews.com - March 16 at 8:15 PM |
 | Proto Labs buys Brooklyn Park building, plans to add 150 new jobs
www.bizjournals.com - March 16 at 5:20 PM |
| Protolabs Expands Manufacturing Capacity with New Building, Added Machines
finance.yahoo.com - March 16 at 9:37 AM |
 | Top Ranked Growth Stocks to Buy for March 15th
www.zacks.com - March 15 at 10:02 AM |
| Top Ranked Growth Stocks to Buy for March 14th - Nasdaq
www.nasdaq.com - March 14 at 11:54 AM |
| Proto Labs Inc (PRLB) Expected to Announce Quarterly Sales of $98.81 Million
www.americanbankingnews.com - March 12 at 5:16 AM |
| Proto Labs Inc (PRLB) Expected to Post Earnings of $0.69 Per Share
www.americanbankingnews.com - March 10 at 1:55 PM |
| Proto Labs Inc (PRLB) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - March 7 at 2:00 PM |
| Maverick Capital Ltd. Purchases 8,792 Shares of Proto Labs Inc (PRLB)
www.americanbankingnews.com - March 3 at 1:48 PM |
| Proto Labs Inc (PRLB) Position Lowered by Royce & Associates LP
www.americanbankingnews.com - March 3 at 9:12 AM |
| First Trust Advisors LP Buys 21,966 Shares of Proto Labs Inc (PRLB)
www.americanbankingnews.com - March 3 at 8:30 AM |
| Proto Labs Inc (PRLB) Shares Bought by Schroder Investment Management Group
www.americanbankingnews.com - March 2 at 9:58 AM |
| Schwab Charles Investment Management Inc. Has $12.23 Million Holdings in Proto Labs Inc (PRLB)
www.americanbankingnews.com - March 1 at 5:28 PM |
| Proto Labs Inc (PRLB) Position Trimmed by Gs Investments Inc.
www.americanbankingnews.com - February 28 at 4:02 PM |
| Proto Labs Inc (PRLB) Stake Lifted by Arizona State Retirement System
www.americanbankingnews.com - February 27 at 4:24 AM |
| Employees Retirement System of Texas Buys Shares of 27,000 Proto Labs Inc (PRLB)
www.americanbankingnews.com - February 26 at 12:21 PM |
| ARK Investment Management LLC Has $17.32 Million Holdings in Proto Labs Inc (PRLB)
www.americanbankingnews.com - February 26 at 5:12 AM |
| Proto Labs Inc (PRLB) Position Lifted by Arrowstreet Capital Limited Partnership
www.americanbankingnews.com - February 25 at 4:18 AM |
| Proto Labs Inc (PRLB) Files 10-K for the Fiscal Year Ended on December 31, 2017
finance.yahoo.com - February 23 at 5:03 PM |
| $98.81 Million in Sales Expected for Proto Labs Inc (PRLB) This Quarter
www.americanbankingnews.com - February 23 at 2:56 AM |
| Brokerages Anticipate Proto Labs Inc (PRLB) to Announce $0.66 EPS
www.americanbankingnews.com - February 21 at 9:20 PM |
| Proto Labs (PRLB) Upgraded to "Buy" by Zacks Investment Research
www.americanbankingnews.com - February 15 at 6:58 AM |
| Proto Labs Inc (PRLB) VP Robert Bodor Sells 1,891 Shares
www.americanbankingnews.com - February 14 at 9:58 PM |
| Proto Labs Inc (PRLB) Director John B. Goodman Sells 2,715 Shares
www.americanbankingnews.com - February 14 at 9:40 PM |
| Proto Labs Inc (PRLB) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - February 10 at 12:14 PM |
| Proto Labs Wraps Up 2017 on a Strong Note
finance.yahoo.com - February 10 at 6:58 AM |
| Proto Labs Reports Record Revenue and Net Income for the Fourth Quarter and Full Year 2017
finance.yahoo.com - February 9 at 6:55 AM |
| Proto Labs (PRLB) Issues Quarterly Earnings Results, Beats Expectations By $0.03 EPS
www.americanbankingnews.com - February 8 at 2:22 PM |
| Proto Labs (PRLB) Tops Q4 Earnings and Revenues
www.zacks.com - February 8 at 6:46 AM |
| What to Expect From Proto Labs (PRLB) This Earnings Season? - Nasdaq
www.nasdaq.com - February 7 at 6:52 AM |
| What to Expect From Proto Labs (PRLB) This Earnings Season?
finance.yahoo.com - February 6 at 3:26 PM |
| Proto Labs (PRLB) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - February 6 at 3:28 AM |
Proto Labs (NYSE:PRLB) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Proto Labs (NYSE:PRLB) Income Statement, Balance Sheet and Cash Flow Statement
Proto Labs (NYSE PRLB) Stock Chart for Monday, April, 23, 2018
Loading chart…
